X-Frame-Options: SAMEORIGIN
: 516-482-9001

Category Archives: FDA Updates

26 Jan

Design Considerations and Premarket Submission Recommendations for Interoperable Medical Devices

FDA wants your comments!! Your chance to be heard!!!!! FDA announced an opportunity for public comment on the guidance document for Design Considerations and premarket Submission Recommendations for Interoperable Medical Devices. In today’s world where technology plays an important role, the Medical Device industry is bringing in new technologies in market. The Healthcare industry is

20 Dec

PACS: An Ounce of Investment in Your Patients.

Proper maintenance of PACS can help the facility to save money. For proper maintenance and upkeep of PACS a facility should have a proper backup system available with well trained staff on how to perform the backup. The software should be always up to date and the manufacturers requirements about the hardware should be followed.

30 Oct

Small Change with big Impact

New Changes to the FDA’s Device Registration and Listing Database NEWS FLASH!!! Guidance for “Transfer of a Premarket Notification (510(k)) Clearance” In December 2014, we posted an FDA Update on the new draft FDA guidance titled “Transfer of a Premarket Notification (510(k)) Clearance–Questions and Answers”. This guidance provided information on how to notify FDA of

27 Oct

FDA wants your comment!! – Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens That Are Not Individually Identifiable

FDA announced an opportunity for public comment on the guidance document for informed consent for in vitro diagnostic device studies using leftover human specimens that are not individually identifiable. FDA regulations do not contain exceptions from the requirements of informed consent on the grounds that the specimens are not identifiable or that they are remnants

09 Oct

Incorporation of (UDIs) in Healthcare settings

On the same date, the Centers for Medicare and Medicaid Services (CMS) published a final rule that specifies the requirements that eligible providers and hospitals must meet to qualify for Electronic Health Record (EHR) incentive payments and solicits feedback about the Electronic Health Record (EHR) Incentive Programs going forward. Goal of this Activity: Incorporation of

30 Sep

The FDA new user fees for Fiscal Year 2016

The FDA new user fees for Fiscal Year 2016 (October 1, 2015 through September 30, 2016) are as follows: FY16 User Fees (in U.S. Dollars) Application Type Standard Fee Small Business Fee 510(k)‡ $5,228 $2,614 513(g) $3,529 $1,765 PMA, PDP, PMR, BLA $261,388 $65,347 panel-track supplement $196,041 $49,010 180-day supplement $39,208 $9,802 real-time supplement $18,297

22 Sep

CDRH Patient Engagement

Clients are being made aware of this new milestone development for the first time in the FDA’s history, through which FDA is establishing an advisory committee focused on patient engagement. The Patient Engagement Advisory Committee will provide advice on complex issues relating to medical devices, the regulation of devices, and their use by patients to

10 Sep

New FDA Regulations for the FOOD INDUSTRY – MAJOR CHANGES

Starting Sept 2016 All our food clients are made aware that the FDA has finally released the final rules on two regulations that will affect the human and animal foods. These changes will be the most comprehensive and dynamic changes to the Food Industry since the 1970’s. The intent is to provide new Safety Requirements

26 Aug

Revised FDA Fees for Issuing Export Certificates for Devices

NEWS FLASH!!! For those of those that ship FDA regulated devices out of the country we are familiar with export certificates. FDA has revised the payment requirements for export certificates, the fees are now: Original Certificates: $175 Subsequent Certificates issued for the same product(s): $85 The maximum number of pages for a certificate is now

Archives